Understanding the Spike Protein in COVID-19 Vaccine in Recombinant Vesicular Stomatitis Virus (rVSV) Using Automated Capillary Western Blots

• Paul F. Gillespie,
• Yanjie Wang,
• Carl Hofmann,
• Laura E. Kuczynski,
• Michael A. Winters,
• Jennifer L. Teyral,
• Christopher M. Tubbs,
• Kelsey Shiflett,
• Nisarg Patel,
• Richard R. Rustandi

Affiliations

Paul F. Gillespie

Analytical Research Development, Merck & Co., Inc., West Point, Pennsylvania, United States

Yanjie Wang

Analytical Research Development, Merck & Co., Inc., West Point, Pennsylvania, United States

Carl Hofmann

Analytical Research Development, Merck & Co., Inc., West Point, Pennsylvania, United States

Laura E. Kuczynski

Vaccine Process Development, Merck & Co., Inc., West Point, Pennsylvania, United States

Michael A. Winters

Vaccine Process Development, Merck & Co., Inc., West Point, Pennsylvania, United States

Jennifer L. Teyral

Research CMC Statistics, Merck & Co., Inc., West Point, Pennsylvania, United States

Christopher M. Tubbs

Analytical Research Development, Merck & Co., Inc., West Point, Pennsylvania, United States

Kelsey Shiflett

Analytical Research Development, Merck & Co., Inc., West Point, Pennsylvania, United States

Nisarg Patel

Analytical Research Development, Merck & Co., Inc., West Point, Pennsylvania, United States

Richard R. Rustandi

Analytical Research Development, Merck & Co., Inc., West Point, Pennsylvania, United States